Louis DeGennaro — SPARQNOW

At-a-Glance

Past President & CEO of The Leukemia & Lymphoma Society (LLS), a $400 million cancer agency.
Architect of the LLS Therapy Acceleration Program®, a venture philanthropy endeavor.
Holds a Ph.D. in biochemistry from the University of California at San Francisco.
Served as Senior Director of Molecular Genetics at Wyeth Pharmaceuticals.
Currently Executive Chairman at Stealth Mode Biotech.
Currently Senior Advisor at Vie Ventures.

Biography

Louis J. DeGennaro, Ph.D.

, is the Executive Chairman at Stealth Mode Biotech and a Senior Advisor at Vie Ventures. He also serves as Managing Director at Cantlous Advisory Partners, LLC. Previously, he was the President and CEO of The Leukemia & Lymphoma Society (LLS) from September 2014, stewarding the operations of the $400 million cancer agency.

He joined LLS in 2005 and was named Chief Mission Officer in 2009, overseeing research, patient access, education, public policy, and advocacy.